Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) has been given a consensus rating of “Hold” by the nineteen research firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, thirteen have issued a hold rating and five have assigned a buy rating to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $23.6071.
A number of equities research analysts have weighed in on BBWI shares. Barclays dropped their price target on shares of Bath & Body Works from $28.00 to $18.00 and set an “equal weight” rating for the company in a research report on Friday, November 21st. Wells Fargo & Company cut their target price on Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, November 21st. The Goldman Sachs Group lowered Bath & Body Works from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $39.00 to $17.00 in a research report on Thursday, November 20th. Telsey Advisory Group cut Bath & Body Works from an “outperform” rating to a “market perform” rating and dropped their price objective for the company from $38.00 to $17.00 in a research note on Friday, November 21st. Finally, Guggenheim assumed coverage on Bath & Body Works in a research note on Tuesday, December 9th. They set a “neutral” rating on the stock.
Check Out Our Latest Stock Report on Bath & Body Works
Insider Buying and Selling at Bath & Body Works
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Parkside Financial Bank & Trust lifted its holdings in shares of Bath & Body Works by 24.6% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock valued at $55,000 after purchasing an additional 364 shares during the last quarter. Parallel Advisors LLC lifted its stake in Bath & Body Works by 63.3% in the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock valued at $37,000 after buying an additional 481 shares during the last quarter. Gabelli Funds LLC boosted its holdings in shares of Bath & Body Works by 1.2% in the third quarter. Gabelli Funds LLC now owns 47,536 shares of the company’s stock valued at $1,225,000 after acquiring an additional 542 shares during the period. Sumitomo Mitsui Trust Group Inc. grew its position in shares of Bath & Body Works by 3.7% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 16,700 shares of the company’s stock worth $430,000 after acquiring an additional 600 shares during the last quarter. Finally, State of Wyoming grew its position in shares of Bath & Body Works by 6.2% during the second quarter. State of Wyoming now owns 11,294 shares of the company’s stock worth $338,000 after acquiring an additional 661 shares during the last quarter. 95.14% of the stock is currently owned by hedge funds and other institutional investors.
Bath & Body Works Stock Up 0.4%
NYSE:BBWI opened at $19.80 on Monday. Bath & Body Works has a 52 week low of $14.27 and a 52 week high of $41.87. The stock’s fifty day moving average is $21.06 and its two-hundred day moving average is $26.15. The company has a market capitalization of $4.05 billion, a P/E ratio of 6.09, a P/E/G ratio of 0.73 and a beta of 1.51.
Bath & Body Works (NYSE:BBWI – Get Free Report) last released its quarterly earnings results on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). The business had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Bath & Body Works had a negative return on equity of 47.35% and a net margin of 9.50%.The business’s revenue for the quarter was down 1.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.49 earnings per share. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. Sell-side analysts anticipate that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.
Bath & Body Works Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, December 5th. Stockholders of record on Friday, November 21st were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 4.0%. The ex-dividend date of this dividend was Friday, November 21st. Bath & Body Works’s dividend payout ratio is currently 24.62%.
Bath & Body Works Company Profile
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Read More
- Five stocks we like better than Bath & Body Works
- Do not delete, read immediately
- How the Rich Retire
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- How Long Will $1M Last in Retirement?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
